We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-2.54%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$49.4B
AUM Growth
-$1.83B
(-3.6%)
Cap. Flow
+$236M
Cap. Flow
% of AUM
0.48%
Top 10 Holdings %
Top 10 Hldgs %
23.11%
Holding
2,899
New
506
Increased
652
Reduced
806
Closed
772
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.93B |
| 2 |
Kenvue
KVUE
|
+$537M |
| 3 |
Humana
HUM
|
+$477M |
| 4 |
AbbVie
ABBV
|
+$441M |
| 5 |
Microsoft
MSFT
|
+$384M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$747M |
| 2 |
Apple
AAPL
|
+$565M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$467M |
| 4 |
McKesson
MCK
|
+$347M |
| 5 |
Intel
INTC
|
+$300M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.79% |
| 2 | Healthcare | 17.06% |
| 3 | Consumer Discretionary | 12.96% |
| 4 | Consumer Staples | 7.45% |
| 5 | Financials | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Collegium Pharmaceutical
COLL
$1.14B
| $8.63M | 0.02% |
386,296
-108,180
| -22% | -$2.47M |
|
677
Fidelity National Information Services
FIS
$21.5B
| $8.62M | 0.02% |
155,958
-176,593
| -53% | -$10.2M |
|
678
Kohl's
KSS
$2.03B
| $8.59M | 0.02% |
409,940
-403,650
| -50% | -$10.2M |
|
|
AXNX
679
DELISTED
Axonics, Inc. Common Stock
AXNX
| $8.57M | 0.02% |
152,686
-725,279
| -83% | -$40.8M |
|
|
HIMX
680
Himax Technologies
HIMX
$2.2B
| $8.56M | 0.02% |
1,466,243
+104,399
| +8% | +$669K |
|
681
Verra Mobility
VRRM
$615M
| $8.51M | 0.02% |
454,888
+381,246
| +518% | +$7.39M |
|
682
Wolfspeed
WOLF
$1.2B
| $8.47M | 0.02% |
+222,239
| New | +$11.6M |
|
683
Post Holdings
POST
$4.12B
| $8.43M | 0.02% |
98,297
+44,924
| +84% | +$3.92M |
|
684
Genius Sports
GENI
$1.73B
| $8.41M | 0.02% |
1,578,390
+1,391,316
| +744% | +$9.21M |
|
685
A.O. Smith
AOS
$8.38B
| $8.41M | 0.02% |
127,169
+74,430
| +141% | +$5.28M |
|
|
NFYS.WS
686
CALL
DELISTED
Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
NFYS.WS
| $8.36M | 0.02% |
796,317
-4,595
| -0.6% | -$281 |
|
|
ACH
687
Accendra Health
ACH
$240M
| $8.33M | 0.02% |
515,352
+247,743
| +93% | +$4.4M |
|
|
TGI
688
DELISTED
Triumph Group
TGI
| $8.3M | 0.02% |
1,083,658
+403,073
| +59% | +$3.94M |
|
689
Golar LNG
GLNG
$4.95B
| $8.26M | 0.02% |
340,576
-233,082
| -41% | -$5.37M |
|
690
Planet Fitness
PLNT
$4.23B
| $8.26M | 0.02% |
167,940
+81,754
| +95% | +$4.95M |
|
691
Brookdale Senior Living
BKD
$3.62B
| $8.25M | 0.02% |
1,992,574
-151,083
| -7% | -$607K |
|
692
ZipRecruiter
ZIP
$318M
| $8.24M | 0.02% |
687,149
+262,142
| +62% | +$4.27M |
|
|
AMWD
693
DELISTED
American Woodmark
AMWD
| $8.2M | 0.02% |
108,446
+12,324
| +13% | +$926K |
|
694
Herc Holdings
HRI
$5.43B
| $8.19M | 0.02% |
+68,879
| New | +$8.99M |
|
|
EXK
695
Endeavour Silver
EXK
$2.32B
| $8.19M | 0.02% |
+3,370,371
| New | +$9.94M |
|
|
RVNC
696
DELISTED
Revance Therapeutics, Inc.
RVNC
| $8.19M | 0.02% |
713,638
+623,110
| +688% | +$12M |
|
697
Huron Consulting
HURN
$1.82B
| $8.14M | 0.02% |
78,190
+58,507
| +297% | +$5.57M |
|
698
John Wiley & Sons Class A
WLY
$2.52B
| $8.14M | 0.02% |
+219,044
| New | +$7.77M |
|
699
American Water Works
AWK
$26.3B
| $8.14M | 0.02% |
65,695
+62,695
| +2,090% | +$8.79M |
|
700
eBay
EBAY
$48.6B
| $8.11M | 0.02% |
+183,935
| New | +$8.21M |
|
Similar funds
Marshall Wace's Q3 2023 Portfolio in Review
As of Q3 2023, Marshall Wace held 2,899 positions worth $49.4B, down 3.6% from $51.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Marshall Wace's Q3 2023 filing shows 506 new, 652 increased, 806 reduced and 772 closed positions. Its largest new stake was Humana: 1,014,185 shares worth $493M. The largest sale was Amazon, an estimated $747M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Marshall Wace's largest Q3 2023 buy was Humana: 1,014,185 shares worth $493M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q3 2023, an estimated $1.93B increase.
- Marshall Wace's biggest Q3 2023 reduction was Amazon, cutting an estimated $747M.
- Marshall Wace fully exited Johnson & Johnson in Q3 2023, selling an estimated $284M.
- Marshall Wace's ten largest holdings make up 23% of its $49.4B portfolio in Q3 2023.
- Marshall Wace opened 506 new positions and closed 772 in Q3 2023.
- Marshall Wace's portfolio value fell 3.6% quarter-over-quarter to $49.4B.
Based on Marshall Wace's 13F filing for Q3 2023, filed 14 Nov 2023.